Concepts (88)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Aortic Arch Syndromes | 1 | 2023 | 19 | 0.910 |
Why?
|
| Norwood Procedures | 1 | 2022 | 191 | 0.690 |
Why?
|
| rac GTP-Binding Proteins | 2 | 2016 | 162 | 0.650 |
Why?
|
| Hypoplastic Left Heart Syndrome | 1 | 2022 | 590 | 0.550 |
Why?
|
| Interleukin-1beta | 3 | 2022 | 972 | 0.540 |
Why?
|
| Perioperative Care | 1 | 2021 | 998 | 0.450 |
Why?
|
| Aortic Diseases | 1 | 2016 | 702 | 0.370 |
Why?
|
| Macrophages | 3 | 2022 | 5648 | 0.330 |
Why?
|
| Cardiac Surgical Procedures | 2 | 2021 | 3539 | 0.330 |
Why?
|
| Plaque, Atherosclerotic | 2 | 2020 | 1487 | 0.330 |
Why?
|
| Inflammation Mediators | 1 | 2016 | 1853 | 0.300 |
Why?
|
| Heart Defects, Congenital | 2 | 2021 | 4657 | 0.300 |
Why?
|
| rac1 GTP-Binding Protein | 2 | 2020 | 242 | 0.290 |
Why?
|
| Asthma | 1 | 2023 | 6109 | 0.240 |
Why?
|
| Atherosclerosis | 2 | 2020 | 3416 | 0.240 |
Why?
|
| Neuropeptides | 2 | 2020 | 941 | 0.210 |
Why?
|
| Circulatory Arrest, Deep Hypothermia Induced | 1 | 2021 | 73 | 0.190 |
Why?
|
| Prostaglandins | 1 | 2022 | 402 | 0.190 |
Why?
|
| STAT3 Transcription Factor | 1 | 2022 | 867 | 0.150 |
Why?
|
| Trachea | 1 | 2023 | 1080 | 0.150 |
Why?
|
| Vascular Endothelial Growth Factor A | 2 | 2022 | 3458 | 0.150 |
Why?
|
| Aorta, Thoracic | 1 | 2023 | 1050 | 0.150 |
Why?
|
| Coronary Artery Disease | 1 | 2016 | 6456 | 0.140 |
Why?
|
| Cardiopulmonary Bypass | 1 | 2021 | 1062 | 0.140 |
Why?
|
| Interleukin 1 Receptor Antagonist Protein | 1 | 2016 | 298 | 0.130 |
Why?
|
| Nonmuscle Myosin Type IIA | 1 | 2014 | 27 | 0.120 |
Why?
|
| Neuroprotective Agents | 1 | 2021 | 950 | 0.120 |
Why?
|
| Receptors, CCR2 | 1 | 2014 | 207 | 0.110 |
Why?
|
| Pulmonary Artery | 1 | 2022 | 1919 | 0.110 |
Why?
|
| NF-kappa B | 1 | 2022 | 2462 | 0.110 |
Why?
|
| Myocytes, Smooth Muscle | 1 | 2016 | 674 | 0.100 |
Why?
|
| Stem Cell Transplantation | 1 | 2021 | 1597 | 0.100 |
Why?
|
| RNA Stability | 1 | 2014 | 328 | 0.100 |
Why?
|
| Brain Diseases | 1 | 2021 | 1541 | 0.100 |
Why?
|
| Apolipoproteins E | 1 | 2016 | 1418 | 0.090 |
Why?
|
| Muscle, Smooth, Vascular | 1 | 2016 | 1483 | 0.090 |
Why?
|
| Acute Kidney Injury | 1 | 2021 | 1841 | 0.080 |
Why?
|
| Aorta | 1 | 2016 | 2027 | 0.080 |
Why?
|
| Transfection | 1 | 2016 | 5786 | 0.080 |
Why?
|
| Heart Diseases | 1 | 2021 | 2764 | 0.080 |
Why?
|
| Up-Regulation | 1 | 2016 | 4115 | 0.070 |
Why?
|
| Neovascularization, Physiologic | 1 | 2014 | 1326 | 0.070 |
Why?
|
| Palliative Care | 1 | 2022 | 3546 | 0.070 |
Why?
|
| Risk Factors | 3 | 2022 | 72413 | 0.070 |
Why?
|
| Biomedical Research | 1 | 2021 | 3326 | 0.060 |
Why?
|
| Coronary Vessels | 1 | 2016 | 3074 | 0.060 |
Why?
|
| Treatment Outcome | 2 | 2022 | 63664 | 0.060 |
Why?
|
| Hydroxymethylglutaryl-CoA Reductase Inhibitors | 1 | 2020 | 3269 | 0.060 |
Why?
|
| Cells, Cultured | 2 | 2020 | 18891 | 0.060 |
Why?
|
| Animals | 6 | 2022 | 166308 | 0.050 |
Why?
|
| Infant, Newborn | 1 | 2022 | 25753 | 0.050 |
Why?
|
| Infant | 1 | 2023 | 35448 | 0.050 |
Why?
|
| Mice, Knockout | 1 | 2016 | 14212 | 0.050 |
Why?
|
| Mice, Inbred C57BL | 2 | 2016 | 21529 | 0.050 |
Why?
|
| Prenylation | 1 | 2020 | 37 | 0.040 |
Why?
|
| Risk Assessment | 1 | 2021 | 23454 | 0.040 |
Why?
|
| Receptors, Granulocyte-Macrophage Colony-Stimulating Factor | 1 | 2020 | 111 | 0.040 |
Why?
|
| Humans | 8 | 2023 | 746070 | 0.040 |
Why?
|
| Time Factors | 1 | 2021 | 39589 | 0.040 |
Why?
|
| Phenotype | 1 | 2016 | 16250 | 0.040 |
Why?
|
| Retrospective Studies | 3 | 2022 | 78293 | 0.040 |
Why?
|
| Child | 2 | 2023 | 78469 | 0.040 |
Why?
|
| Signal Transduction | 2 | 2020 | 23115 | 0.040 |
Why?
|
| Creatinine | 1 | 2021 | 1848 | 0.030 |
Why?
|
| Prognosis | 1 | 2016 | 29072 | 0.030 |
Why?
|
| Genetic Predisposition to Disease | 1 | 2016 | 17435 | 0.030 |
Why?
|
| Nitric Oxide | 1 | 2021 | 2121 | 0.030 |
Why?
|
| X-Ray Microtomography | 1 | 2014 | 429 | 0.030 |
Why?
|
| Regeneration | 1 | 2021 | 1492 | 0.030 |
Why?
|
| Trans-Activators | 1 | 2022 | 2846 | 0.030 |
Why?
|
| Recovery of Function | 1 | 2021 | 2924 | 0.020 |
Why?
|
| Promoter Regions, Genetic | 1 | 2022 | 5761 | 0.020 |
Why?
|
| DNA Primers | 1 | 2014 | 2810 | 0.020 |
Why?
|
| Mice, Transgenic | 1 | 2022 | 9441 | 0.020 |
Why?
|
| Arteries | 1 | 2014 | 1113 | 0.020 |
Why?
|
| Cytokines | 1 | 2022 | 7219 | 0.020 |
Why?
|
| Kidney | 1 | 2021 | 6984 | 0.020 |
Why?
|
| Monocytes | 1 | 2014 | 2544 | 0.020 |
Why?
|
| DNA-Binding Proteins | 1 | 2022 | 9524 | 0.010 |
Why?
|
| Flow Cytometry | 1 | 2014 | 5837 | 0.010 |
Why?
|
| Incidence | 1 | 2021 | 20812 | 0.010 |
Why?
|
| Male | 2 | 2020 | 351098 | 0.010 |
Why?
|
| Disease Models, Animal | 1 | 2020 | 17831 | 0.010 |
Why?
|
| Postoperative Complications | 1 | 2021 | 15341 | 0.010 |
Why?
|
| Cohort Studies | 1 | 2021 | 40505 | 0.010 |
Why?
|
| Female | 1 | 2016 | 382129 | 0.010 |
Why?
|
| Mice | 1 | 2014 | 80065 | 0.000 |
Why?
|
| Aged | 1 | 2020 | 164222 | 0.000 |
Why?
|
Concepts
(88)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(4)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_